about
High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate CancerRegulation of PP2A by Sphingolipid Metabolism and SignalingArsenic sulfide promotes apoptosis in retinoid acid resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET proteinNOX1 supports the metabolic remodeling of HepG2 cellsImmunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors.Sorbitol dehydrogenase overexpression and other aspects of dysregulated protein expression in human precancerous colorectal neoplasms: a quantitative proteomics study.Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancerGlucose-regulated protein 58 modulates β-catenin protein stability in a cervical adenocarcinoma cell lineCracking the ANP32 whips: important functions, unequal requirement, and hints at disease implications.NME genes in epithelial morphogenesis.Silencing of high-mobility group box 2 (HMGB2) modulates cisplatin and 5-fluorouracil sensitivity in head and neck squamous cell carcinoma.Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinomaEvaluation of 9-cis retinoic acid and mitotane as antitumoral agents in an adrenocortical xenograft model.High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistanceDevelopmental function of Nm23/awd: a mediator of endocytosis.The Drosophila metastasis suppressor gene Nm23 homolog, awd, regulates epithelial integrity during oogenesis.Predictive and prognostic protein biomarkers in epithelial ovarian cancer: recommendation for future studies.Biomarker discovery in ovarian cancer.Zinc Finger and X-Linked Factor (ZFX) Binds to Human SET Transcript 2 Promoter and Transactivates SET Expression.Human apurinic/apyrimidinic endonuclease 1.Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer.Expression of set is downregulated by rapamycin in human colorectal cancer cells.Involvement of SET in the Wnt signaling pathway and the development of human colorectal cancer.MYC degradationImmunohistochemical analysis of p53, APE1, hMSH2 and ERCC1 proteins in actinic cheilitis and lip squamous cell carcinoma.Tetra-arsenic tetra-sulfide (As4S 4) promotes apoptosis in retinoid acid -resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET protein.Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment.Proteomic analysis of human epithelial ovarian cancer xenografts in immunodeficient mice exposed to chronic psychological stress.Regulatory network involving miRNAs and genes in serous ovarian carcinoma.
P2860
Q26774902-E300AA4F-8A98-4EA8-B8B8-06BECB27D82EQ27026038-1847E2DE-76E7-4F79-A132-79132225086DQ28538642-1BC153A4-AAE7-4444-8969-B1172243B39AQ28544991-F96EBE88-DC16-411B-A51B-A1FE5BFC70A4Q33387074-65F715FF-DFF1-443F-AE45-34F95D28CCD7Q33583152-2AB1AECE-A138-4944-B9BF-EAC0082EF1FDQ33977247-617DED9A-C22F-413C-A1FA-D143E15B3B89Q34029568-8FD49773-01CB-438C-AC33-7AB21198F567Q34730329-43391325-FA01-4212-9818-7960F48AA5B3Q35915854-A0DC27D5-80A2-472D-89C4-062FE74774B3Q35927823-3155B62B-EBF7-4880-A41F-A548CB717718Q36367144-6878595A-B379-47DD-A722-549148401DADQ36516597-8B948A46-C990-4400-94C9-60D6B08068B3Q37109252-1C9533CC-CDE8-42E8-9724-E1A9BA4A82FCQ37291962-FBE0B208-917A-4416-976B-4E194A50CF25Q37302253-D96DD469-9792-4AF1-91DD-3E53E6D98A0AQ37328373-198E7345-3C74-411E-9A1E-B1DCA46C7AFDQ37346072-1123D88D-4506-46EE-8956-6EE78BEDFADAQ37377505-CF65E1D0-AA86-4B8C-96C2-7B23A88D7430Q37512952-D096DD19-06BA-40B0-A09B-C737E89A05F2Q37562866-649EF558-E307-4046-86D7-07B5F9BCA6FFQ37565457-55F0375D-6517-446E-A26A-0E2F34C71A56Q37652730-714839BA-F072-4B97-8287-BD6153AD3BE6Q38193043-218F68BB-FFAC-4EC9-92C5-B1A8F3B10EE8Q38412001-1233F243-DBBA-4EE1-839E-49994163BA56Q39034077-FDF44A75-117C-47D8-8860-BB198B57469AQ39097201-F07B41DC-B3A5-4F25-9E02-3EF835D8523CQ39592859-46B7073B-EB0B-4D33-9822-4F1C6BF3F8ECQ45874094-58D2D523-3161-40AF-A815-266F79C3B43B
P2860
description
im Juli 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 November 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2006
@uk
name
SET complex in serous epithelial ovarian cancer
@en
SET complex in serous epithelial ovarian cancer
@nl
type
label
SET complex in serous epithelial ovarian cancer
@en
SET complex in serous epithelial ovarian cancer
@nl
prefLabel
SET complex in serous epithelial ovarian cancer
@en
SET complex in serous epithelial ovarian cancer
@nl
P2093
P2860
P356
P1476
SET complex in serous epithelial ovarian cancer
@en
P2093
Christian Lussier
Cécile Le Page
Diane M Provencher
Marie-Claude Guyot
Patricia N Tonin
P2860
P304
P356
10.1002/IJC.22054
P577
2006-11-01T00:00:00Z